A selective and efficient synthetic route to borylhalosilanes has been developed via the rearrangement reactions of N-heterocyclic tetrylenes with amino-borondihalides. Functionalized amidinato-substituted silylenes of the type PhC(NtBu)2SiR (R = Cl, OtBu, Cbz, Si(SiMe3)3, N(SiMe3)2) react cleanly with amino-borondihalides to afford borylhalosilanes in isolated yields of 30–40%. The process proceeds through migration of the amidinato ligand from Si to B, facilitating ligand exchange between Si(II) and B(III) centers. Notably, the heavier group 14 analogues PhC(NtBu)2ECl; E = Ge, Sn follow a divergent pathway involving boron insertion into the amidinate backbone, generating EBr2 precipitates. The resulting products, LBSiBr3Cbz (2a), LBSiBr3tBuCbz (2b), LBSiBr2(OtBu)Cbz (3), LBSiBr2(Cbz)2(4), LBSiBr2N(SiMe3)2Cbz (5), LBSiBr2Si(SiMe3)3Cbz (6), and LBClCbz (7) (L = PhC(NtBu)2), feature Si(IV) and B(III) centers and were comprehensively characterized by multinuclear NMR spectroscopy and single-crystal X-ray diffraction studies. These findings establish a versatile platform for generating structurally diverse borylhalosilanes and highlight striking reactivity differences across the group 14 series.
Gothe et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: